outcomes research

Research in Review

11/10/2016

JCP Editors

Tivozanib was well-tolerated and showed promising antitumor activity in patients with soft tissue sarcoma overexpressing vascular endothelial growth factors (VEGF), supporting efforts for further research, according...

...

11/10/2016

Journal of Clinical Pathways

Research in Review

Immunotherapies May Pose Severe Heart Risk

11/04/2016

JCP Editors

Researchers have identified a serious and potentially fatal adverse event associated with immunology drugs, according to a study published in the New England Journal of Medicine. Immune checkpoint inhibitors have...

...

11/04/2016

Journal of Clinical Pathways

Research in Review

Prior Malignancies Do Not Affect CML Outcomes

11/02/2016

JCP Editors

Patients with chronic myeloid leukemia (CML) and a history of prior malignancies appear to have the same outcomes as patients with no prior malignancies, according to a study published in Cancer. ------ Related...

...

11/02/2016

Journal of Clinical Pathways

Neutrophil-to-Lymphocyte Ratio Not a Prognostic or Predictive Marker for Bladder Cancer

10/31/2016

JCP Editors

The neutrophil-to-lymphocyte ratio (NLR) may not be as reliable as previously believed at predicating cancer progression and which drugs will be the most effective, according to results published in Cancer. Risk...

The...

10/31/2016

Journal of Clinical Pathways

Research in Review

Researchers Clarify Data for Epi proColon Used in USPSTF Guidelines

10/28/2016

JCP Editors

The recently published US Preventative Services Task Force (USPSTF) updated recommendation statement on colorectal cancer screening referenced multiple available options for colorectal screening, including...

The...

10/28/2016

Journal of Clinical Pathways

Research in Review

Surgery Plus Chemoradiotherapy Better for Patients With Rectal Cancer

10/25/2016

JCP Editors

Patients with stage II or stage III rectal cancer may have better outcomes when treated with surgery and chemoradiotherapy than those who receive chemoradiotherapy alone, according to an article published in JAMA...

...

10/25/2016

Journal of Clinical Pathways

Research in Review

Androgen Therapy May Improve Survival in Elderly Patients With Leukemia

10/24/2016

JCP Editors

Maintenance therapy with norethandrolone may improve survival in elderly patients with acute myeloid leukemia (AML) without increasing toxicity, according to a study published in the Journal of Clinical Oncology....

...

10/24/2016

Journal of Clinical Pathways

Research in Review

Treatment With Chemotherapy Drives Urothelial Cancer Resistance

10/21/2016

JCP Editors

Most patients with metastatic urothelial cancer will become resistant to therapy. New research published in Nature Genetics showed that chemotherapy also shapes the genetic evolution of remaining urothelial cancer...

Most...

10/21/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of October 16-22

10/20/2016

JCP Editors

A recent review of more than 10 years of published clinical data revealed that the use of what type of therapy in regimens for gastroenteropancreatic neuroendocrine tumors (GEPNETs) could improve outcomes, minimize...

A...

10/20/2016

Journal of Clinical Pathways

Research in Review

Study Identifies Steep Price Hikes for Older Cancer Drugs

10/17/2016

JCP Editors

The rising cost of cancer drugs continues to draw criticism from leading academic researchers, and threatens health care budgets. In a new study, researchers found that the price of older drugs increased more in a...

The...

10/17/2016

Journal of Clinical Pathways